Showing 461 - 480 of 599 results
Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it. Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.
Collaborators used X-ray imaging to understand the fine detail of how a damaging fungal pathogen reduces leaf function and grain yield of wheat crops.
Australian-first detector to accelerate cancer research unveiled.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
Consultant appointed to consider a variety of financial, manufacture and import options.
Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.
ANSTO can confirm it has completed its 9th successful export of spent fuel. The spent fuel, from OPAL, ANSTO’s multipurpose reactor, has gone to France for reprocessing.
Dr Peter Kappen manages the Spectroscopy Group at the Australian Synchrotron.
The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success
The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.
Defence Materials Technology Centre honours achievements of two ANSTO collaborators.
The National Deuteration Facility has supported industry through the synthesis of deuterated mineral oil, which was supplied to Japanese chemical manufacturer Mitsui Chemicals. Mitsui Chemicals specialises in polymeric materials for packaging, appliances, construction and other applications.
Research explores how structure contributes to function in food